Clinical Trial

Deep Brain Stimulation for Refractory Trigeminal Neuralgia with a Pontine Lesion

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated December 12, 2024 (before its estimated October 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to assess the feasibility of deep brain stimulation for refractory trigeminal neuralgia due to a pontine lesion, as is usually seen in the context of multiple sclerosis. These patients usually have severe intractable facial pain and current medical and surgical options generally fail to achieve long lasting pain relief. Hoping to improve pain control in this population, the investigators of this trial propose a novel technique consisting of implanting a deep brain stimulation lead within the pontine lesion to modulate the generation of pain signals.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-07-05; most recent amendment 2024-12-06.
Status change: Not Yet Recruiting → Recruiting 2024-11-06
Trial Details
NCT Number NCT05451251
Lead Sponsor Université de Sherbrooke
Conditions Trigeminal Neuralgia
Enrollment 6 participants
Start Date 2024-10-15
Primary Completion 2025-10-15 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2024-12-12